SOMERSET, N.J., Nov. 8 /PRNewswire-FirstCall/ -- Ventiv Health, Inc. announced today that it will present at CIBC's Fifteenth Annual Healthcare Conference taking place at the Plaza Hotel in New York November 8 - 10, 2004. Ventiv's presentation will take place on Wednesday, November 10th at 3:00pm with a breakout session immediately following.
John Emery, Ventiv's Chief Financial Officer will provide an overview of Ventiv Health including a review of recently reported third quarter results (announced on November 8th) and commentary on the Company's most recent acquisition of Smith Hanley which closed on October 13.
The 2004 CIBC World Markets Healthcare Conference will feature informative presentations and panels by leading public and private companies and professionals in the pharmaceutical, biotechnology, medical device and healthcare services industries. The audio portion of Ventiv's presentation will be web cast live and available at http://www.ventiv.com/.
About Ventiv Health
Ventiv Health, Inc. is a leading provider of late-stage clinical, sales, marketing and compliance solutions to the world's largest pharmaceutical companies as well as to emerging and specialty pharmaceutical and biotech organizations. Ventiv's clients include more than 75 pharmaceutical and biotech organizations, including virtually all of the top 20 global pharmaceutical companies.
The Ventiv delivery model is flexible and client-focused, enabling Ventiv to rapidly respond to changing client needs and market conditions across the full spectrum of late-stage clinical, sales, marketing and compliance services, with both integrated and independent programs. These include: Sales and Marketing Teams (Ventiv Sales and Marketing Teams(TM)), Clinical Staffing and Recruiting (Smith Hanley Corporation), Planning and Analytics (Health Products Research(R)), Sample Accountability/Patient Assistance Programs (The Franklin Group), Marketing Support (PROMOTECH), Recruitment (Ventiv Recruitment Services(TM)), Professional Development and Training (Ventiv Professional Development Group(TM)), Data Solutions (Total Data Solutions(TM)) and Clinical Support (The Therapeutics Institute(TM)). Ventiv is a multi- disciplinary company with a singular focus on providing excellence in customized solutions to meet clients' late-stage clinical, sales, marketing and compliance objectives. For more information on Ventiv Health, visit http://www.ventiv.com/.
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements involve known and unknown risks that may cause Ventiv Health's performance to differ materially. Such risks include, without limitation: changes in trends in the pharmaceutical industry or in pharmaceutical outsourcing; our ability to compete successfully with other services in the market; our ability to maintain large client contracts or to enter into new contracts; uncertainties related to future incentive payments; and, our ability to operate successfully in new lines of business. Readers of this press release are referred to documents filed from time to time by Ventiv Health Inc. with the Securities and Exchange Commission for further discussion of these and other factors.
Ventiv Health, Inc.CONTACT: John Emery, CFO of Ventiv Health, Inc., +1-732-537-4804,investor@ventiv.com; Felicia Vonella, +1-212-867-1762,fvonella@lazarpartners.com, or Kellie Walsh, +1-646-871-8480,kwalsh@lazarpartners.com, both of Lazar Partners Ltd. for Ventiv Health,Inc.
Web site: http://www.ventiv.com/